Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2012-03-23 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Attendance formalities (Dutch).pdf
AGM Information Classification · 99% confidence The document text explicitly details the 'Formaliteiten voor deelname' (Formalities for participation) in the 'algemene vergadering' (General Meeting) of UCB NV scheduled for April 26, 2012. It outlines registration deadlines, procedures for submitting intent to participate, rules for proxies (volmachten), and procedures for submitting shareholder proposals and questions. These elements are characteristic of preparatory materials or announcements related to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2012-03-23 Dutch
CA Janssen.pdf
Board/Management Information Classification · 98% confidence The document text consists of a brief biography of an individual named Charles-Antoine Janssen, detailing his professional history, education, and current non-profit involvement. This type of content, focusing on the background of a director or senior executive, strongly aligns with the description of Board/Management Information, which covers changes in the company's board of directors or senior management. It is not a financial report, a legal filing, or a meeting announcement. Therefore, the appropriate code is MANG.
2012-03-23 English
Comptes annuels UCB SA 2011 (signed).pdf
Annual Report Classification · 95% confidence The document is a formal Belgian 'Comptes Annuels' (Annual Accounts) filing for UCB SA. It contains structured financial data, reporting periods (01/01/2011 to 31/12/2011), and lists of directors. This constitutes a full annual financial report rather than an announcement or a summary, fitting the definition of an Annual Report (10-K equivalent for non-US entities). FY 2011
2012-03-23 French
2011 annual report - NL - dynamic.pdf
Annual Report Classification · 95% confidence The document is a comprehensive review of UCB's performance, strategy, and financial outlook for the fiscal year 2011. It includes a 'Letter to Stakeholders' from the Chairman and CEO, detailed discussions on product portfolios (Cimzia, Vimpat, Neupro, Keppra), R&D pipeline updates, financial targets, and dividend proposals. Given the depth of the content, the inclusion of financial metrics, and the strategic overview, it functions as an Annual Report. Although it is an excerpt, it contains the substantive narrative and financial data characteristic of an Annual Report (10-K equivalent for non-US entities). FY 2011
2012-03-23 Dutch
UCB SA audit opinion EN.pdf
Audit Report / Information Classification · 99% confidence The document is explicitly titled 'Statutory auditor's report to the general shareholders' meeting on the annual accounts as of and for the year ended 31 December 2011'. It contains an 'Unqualified opinion on the annual accounts' and 'Additional remarks and information' from the auditor (PwC). This content perfectly matches the definition of a standalone Audit Report/Information, which is categorized as 'AR', distinct from the full Annual Report (10-K) or an announcement of a report (RPA/RNS). The document length (6991 chars) is substantial, indicating it is the report itself, not just a brief announcement. FY 2011
2012-03-23 English
Rapport de Gestion du CA 2011 (signed).pdf
AGM Information Classification · 95% confidence The document is titled "RAPPORT DE GESTION DU CONSEIL D'ADMINISTRATION A L'ASSEMBLEE GENERALE ORDINAIRE DU 26 AVRIL 2012" (Management Report of the Board of Directors to the Ordinary General Meeting of April 26, 2012). It explicitly states that it is presenting the report for the past fiscal year (ending December 31, 2011) for approval at the AGM. It also references the 'Rapport Annuel 2011' (Annual Report 2011) for detailed activities and results, suggesting this document is the specific management report component presented at the AGM, often accompanying the full annual filing or serving as the primary document for the meeting itself. Since it is a report presented *to* the AGM, and it discusses the financial results and dividend proposal for shareholder approval, it strongly aligns with the context of an Annual General Meeting (AGM) presentation/report, rather than the comprehensive 10-K itself, or just a simple dividend announcement. Given the options, AGM-R (AGM Information) is the most fitting category for the management report presented at the meeting.
2012-03-23 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.